Clinical Trials Directory

Trials / Completed

CompletedNCT04918134

Investigation on Diagnosis and Treatment of Helicobacter Pylori Infection by Gastroenterologists in Shandong Province

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Shandong University · Academic / Other
Sex
All
Age
Healthy volunteers

Summary

Helicobacter pylori can lead to a variety of digestive system diseases.The eradication of Helicobacter pylori plays an importment role for the treatment of gastrointestinal ulcer and prevention of gastric cancer .Compared with other countries and regions in the world, the infection rate of Helicobacter pylori in China can reach more than 50%. The non-standard diagnosis and treatment of Helicobacter pylori greatly reduces its eradication rate and increases its drug resistance.Therefore, it is very important to strengthen the standardization of diagnosis and treatment to improve the eradication rate. The purpose of this study is to investigate the diagnosis and treatment status of Helicobacter pylori among gastroenterologists in general hospitals in Shandong Province.It can help us to understand the actual situation of diagnosis and treatment of Helicobacter pylori in hospitals at all levels, and to provide targeted diagnosis and treatment training for doctors.

Conditions

Timeline

Start date
2021-07-10
Primary completion
2021-08-20
Completion
2021-10-07
First posted
2021-06-08
Last updated
2021-10-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04918134. Inclusion in this directory is not an endorsement.

Investigation on Diagnosis and Treatment of Helicobacter Pylori Infection by Gastroenterologists in Shandong Province (NCT04918134) · Clinical Trials Directory